Menu

Intuitive Surgical, Inc. ISRG

Full chart Compare
Set alert

Price alert · ISRG

All alert types
450.04 USD -10.52 (-2.28%)

At closeNov 10, 2026, 5:50 PM EST

452.00 +1.96 +0.44%

After hours · Nov 10, 5:50 PM ET

444.16 Day range 458.80
328.57 52-week range 603.88
YTD
-20.54%
1 year
-21.90%
Market cap
156.00B
Revenue (ttm)
11.58B
Profit margin
25.54%
EPS (ttm)
8.27
Shares out
346.64M
P/E ratio
54.42
Forward P/E
36.09
YTD return
-20.54%
1-year return
-21.90%
Volume
1.66M
Avg volume
2.44M
Open
458.00
Previous close
460.56
Day's range
444.16 – 458.80
52-week range
328.57 – 603.88
Beta
1.44
Analysts
Buy
Price target
486.57 (+8.1%)
Earnings date
Jan 28, 2027

5D -24.15 (-5.09%)

460480WedThuFriMonTue450.04

Key statistics

Enterprise value
155.74B
PEG ratio
2.04
Price / sales
13.47
Price / book
9.76
Dividend yield
0.00%
Payout ratio
0.00%
Revenue growth
21.70%
Free cash flow
3.43B
Total cash
4.04B
Total debt
0
Return on equity
17.93%
Short % of float
2.12%
50-day average
411.69
200-day average
430.88

Financials — quick view

All financials
ISRG Revenue — quarterly 3.05B
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026
ISRG Net income — quarterly 522.80M
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026
ISRG EPS — quarterly 1.50
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026

Earnings

ISRG recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Jan 28, 2027Dec 30, 20262.96———
Oct 20, 2026Sep 30, 20262.653.00+0.35+13.21%
Jul 16, 2026Jun 30, 20262.512.80+0.29+11.55%
Apr 21, 2026Mar 31, 20262.512.80+0.29+11.55%
Jan 22, 2026Dec 31, 20252.272.53+0.26+11.45%
Oct 21, 2025Sep 30, 20251.992.40+0.41+20.60%

Upgrades / downgrades

ISRG analyst upgrades and downgrades
DateFirmActionFromTo
Oct 21, 2026Leerink PartnersmainOutperformOutperform
Oct 21, 2026JP MorganmainOverweightOverweight
Oct 21, 2026Evercore ISI GroupmainIn-LineIn-Line
Oct 21, 2026Wells FargomainOverweightOverweight
Oct 21, 2026TD CowenreitBuyBuy
Oct 21, 2026BarclaysmainOverweightOverweight

About Intuitive Surgical, Inc.

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of customer service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. It sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.

Sector
Healthcare
Industry
Medical Instruments & Supplies
Country
United States

News

Your note

Sign in to keep a note on ISRG — it syncs with the Stock Master app.

Insider holders

ISRG insider holders
InsiderRelationLatest transactionDateShares held
BARRATT CRAIG HDirectorSaleNov 3, 202627,948
CHARLTON HENRY LOfficerConversion of Exercise of derivative securityFeb 26, 202611,610
GUTHART GARY SDirectorSaleNov 3, 20260
JEDDI IMANOfficerSaleMay 31, 202633,112
JOHNSON AMAL MDirectorConversion of Exercise of derivative securityApr 29, 202613,545
LOEB GARYOfficerConversion of Exercise of derivative securityOct 8, 20266,636

Institution ownership

ISRG institution ownership
Holder% heldSharesValueReported
Blackrock Inc.8.66%30,024,64813.51BJun 29, 2026
Vanguard Capital Management LLC6.67%23,131,09910.41BJun 29, 2026
State Street Corporation4.63%16,063,0407.23BJun 29, 2026
Invesco Ltd.3.42%11,843,5635.33BJun 29, 2026
Price (T.Rowe) Associates Inc3.25%11,256,5705.07BJun 29, 2026
Geode Capital Management, LLC2.46%8,542,3343.84BSep 29, 2026

Fund ownership

ISRG fund ownership
Holder% heldSharesValueReported
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.24%11,243,4685.06BJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard 500 Index Fund2.65%9,176,4094.13BJun 29, 2026
Invesco QQQ Trust, Series 12.13%7,379,1133.32BSep 29, 2026
iShares Trust-iShares Core S&P 500 ETF1.36%4,707,5332.12BSep 29, 2026
Fidelity Concord Street Trust-Fidelity 500 Index Fund1.32%4,591,1872.07BSep 29, 2026
SPDR S&P 500 ETF TRUST-State Street SPDR S&P 500 ETF Trust1.26%4,370,7461.97BSep 29, 2026